This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Aventis Recherche & Développement. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ravi Chari and His Patent in Antibody Formulations.
Introduction
Ravi Chari is an inventor associated with Cambridge, Massachusetts, and Sanofi-Aventis Recherche & Développement. His patent work includes a formulation intended to support subcutaneous administration of anti-CD38 antibodies.
Latest Patents
Chari is associated with 1 patent: “Formulations of Anti-CD38 Antibodies for Subcutaneous Administration.” The patent concerns formulations designed for delivering anti-CD38 antibodies by injection under the skin.
Career Highlights
Chari’s listed patent reflects work in pharmaceutical formulation and antibody delivery. The available information identifies Sanofi-Aventis Recherche & Développement as his company.
Collaborations
His listed coworkers include Sylvain Huille and Thomas Ballet.
Conclusion
Ravi Chari’s patent activity is represented by an invention focused on formulating anti-CD38 antibodies for subcutaneous administration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile